Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BYBiology

Extracellular Vesicles in Neonatology: Have We Found the Magic Bullet?

  • Paraskevi Papadogeorgou1
  • Andreas G Tsantes2,3
  • Serena Valsami4
  • Sotirios P Fortis5
  • Anastasios G Kriebardis5
  • Vasiliki Mougiou1
  • Zoi Iliodromiti1
  • Theodora Boutsikou1
  • Nicoletta Iacovidou1
  • Rozeta Sokou1
5 affiliations
  1. 1Neonatal Department, Aretaieio Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  2. 2Laboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  3. 3Microbiology Department, "Saint Savvas" Oncology Hospital, 11522 Athens, Greece.
  4. 4Laboratory of Hematology and Blood Bank Unit, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  5. 5Laboratory of Reliability and Quality Control in Laboratory Hematology (HemQcR), Department of Bio-Medical Sciences, School of Health & Caring Sciences, University of West Attica (UniWA), 12243 Athens, Greece.
Read full textPDFDOICite

Abstract

Extracellular vesicles (EVs) represent nanoparticles released by numerous cell types and exerting distinct biological roles. Extracellular vesicles are enclosed in a lipid layer and contain proteins, lipids, nucleic acids, carbohydrates or even mitochondria. The fundamental utility of EVs is intercellular communication, while their implication in various biological processes, such as inflammation and hemostasis, is well-documented. Growing evidence indicates the significant usefulness of EVs as biomarkers in certain prematurity-related diseases, like bronchopulmonary dysplasia (BPD) and necrotizing enterocolitis (NEC). Moreover, many in vitro and in vivo studies have been undertaken in order to explore the potential therapeutic impact of EVs in BPD, NEC and retinopathy of prematurity (ROP), some of them yielding promising results. The present narrative review aims towards the summarization of the existing data on the application of EVs in diverse neonatal disorders, such as BPD, NEC, ROP, sepsis, multi-organ failure, coagulopathy and brain injury. The widespread investigation of EVs in neonatology and their potential implementation in clinical practice may lead towards a revolutionary approach and management of neonatal diseases, as well as an innovative perception of prematurity.

Related

  1. Editorial: Investigating the role of extracellular vesicles in cardiovascular disease mechanisms
    Jona Benjamin Krohn, Elena Aikawa
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  2. ICAM-5: A marker for neuronally derived extracellular vesicles
    Piper Deleon, Reagan Hattenberger, Sarah Rahman +2
    iSciencePeer-reviewedCC BY-NC-ND 4.0Molecular biology & gene regulationCell biologyCrossrefCell Press
  3. Editorial: Unlocking the potential of extracellular vesicles in tumor immunity and drug resistance
    Yu Fu, Tianzhao Du, Huizhe Xu +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  4. Quantitative lipidomics reveals Lipid perturbation of plasma apoptotic extracellular vesicles during physiological aging
    Maojiao Li, Haisen Huang, Qi Tang
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. Extracellular vesicles orchestrate immune suppression and immune exclusion in cancer.
    Seung-Jae Lee, Jaehoon Bae, Seong-Min Hong +1
    International journal of biological sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC

Cite

BibTeXRIS
BibTeX
@article{papadogeorgou2026extracellular,
  title = {{Extracellular Vesicles in Neonatology: Have We Found the Magic Bullet?}},
  author = {Paraskevi Papadogeorgou and Andreas G Tsantes and Serena Valsami and Sotirios P Fortis and Anastasios G Kriebardis and Vasiliki Mougiou and Zoi Iliodromiti and Theodora Boutsikou and Nicoletta Iacovidou and Rozeta Sokou},
  journal = {Biology},
  year = {2026},
  month = oct,
  doi = {10.3390/biology15191734},
  url = {https://europepmc.org/article/MED/42883409},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Extracellular Vesicles in Neonatology: Have We Found the Magic Bullet?
AU  - Paraskevi Papadogeorgou
AU  - Andreas G Tsantes
AU  - Serena Valsami
AU  - Sotirios P Fortis
AU  - Anastasios G Kriebardis
AU  - Vasiliki Mougiou
AU  - Zoi Iliodromiti
AU  - Theodora Boutsikou
AU  - Nicoletta Iacovidou
AU  - Rozeta Sokou
PY  - 2026
DA  - 2026/10/01
JO  - Biology
DO  - 10.3390/biology15191734
UR  - https://europepmc.org/article/MED/42883409
AB  - Extracellular vesicles (EVs) represent nanoparticles released by numerous cell types and exerting distinct biological roles. Extracellular vesicles are enclosed in a lipid layer and contain proteins, lipids, nucleic acids, carbohydrates or even mitochondria. The fundamental utility of EVs is intercellular communication, while their implication in various biological processes, such as inflammation and hemostasis, is well-documented. Growing evidence indicates the significant usefulness of EVs as biomarkers in certain prematurity-related diseases, like bronchopulmonary dysplasia (BPD) and necrotizing enterocolitis (NEC). Moreover, many in vitro and in vivo studies have been undertaken in order to explore the potential therapeutic impact of EVs in BPD, NEC and retinopathy of prematurity (ROP), some of them yielding promising results. The present narrative review aims towards the summarization of the existing data on the application of EVs in diverse neonatal disorders, such as BPD, NEC, ROP, sepsis, multi-organ failure, coagulopathy and brain injury. The widespread investigation of EVs in neonatology and their potential implementation in clinical practice may lead towards a revolutionary approach and management of neonatal diseases, as well as an innovative perception of prematurity.
SN  - 2079-7737
ER  -